Consensus TaiMed Biologics Inc.

Equities

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
83 ^TWD	+0.61%		-0.12%	+1.22%

Mar. 20	TaiMed Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 13	Taimed Biologics and AcedrA Biopharmaceticals Partner to Commercialize Trogarzo in the Middle East and North Africa Region	CI

a4e.4vypBh528w9tCTPOIbk-NnjWFo63uoRHl3QKaDYsv5g.qsrvaHs4nVklPlKMFMpxcSC-Veb43Lwz1B5NAkxW3de3yNpNThikRSswWA~cbdd45ae9245d0eb14768e8ea704400c

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

83 TWD

Average target price

133.7 TWD

Spread / Average Target

+61.07%

High Price Target

173 TWD

Spread / Highest target

+108.43%

Low Price Target

108.1 TWD

Spread / Lowest Target

+30.19%

Trading Rating

Investor Rating

ESG Refinitiv

C-